Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled trial to determine if administration
of intravenous thiamine will lead to quicker resolution of acidosis in patients admitted to
the hospital with diabetic ketoacidosis. The investigators will secondarily investigate
whether thiamine improves cellular oxygen consumption, shortens intensive care unit (ICU) and
hospital stay or decreases hospital resource utilization.
Phase:
Phase 2
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)